Children's probiotic and prebiotic

ArtaBiotic Baby Sachets

Children's synbiotic with vitamin D3

A children's synbiotic containing two probiotic strains, fructooligosaccharides, 3 billion CFU, and 400 IU vitamin D3 per sachet.

Product details

Composition, listed uses, and product guidance

Identity and pack

Dosage form
Banana-flavoured oral sachet
Pack size
30 one-gram sachets
Classification
Natural product (probiotic)

Composition

Probiotic strains
  • Lacticaseibacillus rhamnosus GG
  • Bifidobacterium lactis BS01
Total probiotic amount
3 billion CFU per sachet
Vitamin D3
400 international units (IU)
Other ingredients
Fructooligosaccharide, sucralose, maltodextrin, cellulose and banana flavour
Allergens
None

Use information

Listed uses
  • Improvement of digestive problems including colic, bloating, constipation, and diarrhoea associated with bacterial or viral infection or antibiotic use
  • Improvement of lactose intolerance
  • Support for immune-system function
  • Improvement of allergy symptoms and reduction in allergy incidence
  • Support for bone growth and strength
Listed age range
Children over 12 years
Directions
As directed by a physician, or one sachet daily
Preparation
Add one sachet to yoghurt, water, lukewarm milk, or fruit juice and consume.

Warnings, adverse effects and storage

Oral antibiotics
A minimum two-hour interval is recommended.
Adverse-effect statement
No adverse effects were reported when used at the recommended amount.
Shelf life
Two years
Licence holder
Behyan Teb Arta

Related scientific references

  1. The effects of Lacticaseibacillus rhamnosus GG supplementation on gastrointestinal and respiratory outcomes: a systematic review and meta-analysis of randomized controlled trials — Food & Function, 2025.
  2. The effectiveness of Lactobacillus rhamnosus GG in the treatment of infantile colic: a systematic review and meta-analysis — Translational Pediatrics, 2024.
  3. Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: a systematic review with meta-analysis — World Journal of Gastroenterology, 2019.
  4. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults — Alimentary Pharmacology & Therapeutics, 2015.
  5. Lactobacillus rhamnosus GG for Cow’s Milk Allergy in Children: A Systematic Review and Meta-Analysis — Frontiers in Pediatrics, 2021.
  6. Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials — American Journal of Clinical Nutrition, 2022.
  7. Role of Lacticaseibacillus rhamnosus GG in the Management of Respiratory Diseases: A Systematic Review and Meta-Analysis — Preventive Nutrition and Food Science, 2025.
  8. Lactobacillus rhamnosus GG Supplementation for Preventing Respiratory Infections in Children: A Meta-analysis of Randomized, Placebo-controlled Trials — Indian Pediatrics, 2013.
  9. Lactobacillus GG and other probiotics in pediatric food allergy treatment: a network meta-analysis — Frontiers in Nutrition, 2025.
  10. Bifidobacterium lactis CCT 7858 Improves Gastrointestinal Symptoms by Antibiotics Treatment: a Double-Blind, Randomized, Placebo-Controlled Trial — Probiotics and Antimicrobial Proteins, 2023.
  11. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12® in infant colic: A randomised, double blind, placebo-controlled trial — Alimentary Pharmacology & Therapeutics, 2019.
  12. Review and Perspectives on Bifidobacterium lactis for Infants’ and Children’s Health — Microorganisms, 2023.
  13. Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis — BMJ, 2011.